Perspectives

Insights generation to identify priority actions to maximize launch of a gene therapy asset in rare patient segments across key growth markets

Program of insights work to shape a distinctive market position and impactful healthcare professional (HCP)-directed communications to shift beliefs, drive launch uptake and build brand loyalty

COVID-19 has intensified many existing trends. The lessons learned and applied under this pressure should enhance decision making in the UK – and perhaps these principles might be applied in other countries.